BMI Mostly Doesn't Impact DOACs, Except Maybe at the Extreme

There are indications of attenuated benefits, or perhaps even a warfarin advantage, at very high BMIs and body weights.

Related Keywords

Boston , Massachusetts , United States , Bayer Janssen , Robert Giugliano , Siddharth Patel , Bishoy Ragheb , Daiichi Sankyo , Boehringer Ingelheim , Pharmd Va Eastern Colorado Health Care System , Bristol Myers Squibb , Harvard Medical School , Colorado Health Care System ,